Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Age
65–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
\- Hypertension defined by a MSSBP \>=150 mmHg (untreated patients) or patients on current anti-hypertensive treatment who remain uncontrolled (i.e. MSSBP \>140 mmHg)
Randomisation mean 24h blood pressure above 130/80 mmHg
In addition the patients must fulfill, at least, one of the following criteria:
Controlled type II Diabetes mellitus Hypercholesteremia, currently treated with lipid-lowering drugs Metabolic syndrome MI, CABG or PTCA more than one year ago Stroke or transient ischemic cerebral attack more than one year ago Documented history of peripheral vascular disease, increased IMT, or carotid plaques Documented history of LVH Elderly \>65 years
You may not be if
\- MSSBP \>=180 mmHg and/or MSDBP \>= 110 mmHg at any time from Visit 1 to Visit 3
Inability to discontinue all prior anti-hypertensive medications safely for a period of three weeks
Mandatory indication for any concomitant medication for coronary artery disease or any other disease that is not allowed during this study.
